![](https://ml.globenewswire.com/media/181b3799-c834-4afc-802f-1077e2d1c0d8/small/exagen-full-rgb-yahoo-600x216-png.png)
Exagen Inc. Announces Study on the Long-Term Effects of COVID-19 Infection in the Development of Autoimmune Diseases
SAN DIEGO, March 29, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that it will collaborate with Emory University on a new …